| Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis X Xiong, H Kuang, S Ansari, T Liu, J Gong, S Wang, XY Zhao, Y Ji, C Li, ... Molecular cell 75 (3), 644-660. e5, 2019 | 579 | 2019 |
| Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results RH Advani, AJ Moskowitz, NL Bartlett, JM Vose, R Ramchandren, ... Blood, The Journal of the American Society of Hematology 138 (6), 427-438, 2021 | 146 | 2021 |
| A new computational drug repurposing method using established disease–drug pair knowledge N Saberian, A Peyvandipour, M Donato, S Ansari, S Draghici Bioinformatics 35 (19), 3672-3678, 2019 | 49 | 2019 |
| Brentuximab vedotin and nivolumab for relapsed or refractory classic Hodgkin lymphoma: long-term follow-up results from the single-arm phase 1/2 study AJ Moskowitz, RH Advani, NL Bartlett, JM Vose, R Ramchandren, ... Blood 134, 238, 2019 | 28 | 2019 |
| SPATIAL: a system-level PAThway impact AnaLysis approach B Bokanizad, R Tagett, S Ansari, BH Helmi, S Draghici Nucleic acids research 44 (11), 5034-5044, 2016 | 23 | 2016 |
| A novel pathway analysis approach based on the unexplained disregulation of genes S Ansari, C Voichita, M Donato, R Tagett, S Draghici Proceedings of the IEEE 105 (3), 482-495, 2016 | 17 | 2016 |
| Preliminary results of a phase 1 study of sea-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (PDAC). DL Bajor, M Gutierrez, GM Vaccaro, A Masood, U Brown-Glaberman, ... Journal of Clinical Oncology 40 (4_suppl), 559-559, 2022 | 10 | 2022 |
| An approach to infer putative disease-specific mechanisms using neighboring gene networks S Ansari, M Donato, N Saberian, S Draghici Bioinformatics 33 (13), 1987-1994, 2017 | 10 | 2017 |
| Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas AL Coveler, DC Smith, T Phillips, BD Curti, S Goel, AN Mehta, TM Kuzel, ... Journal for immunotherapy of cancer 11 (6), 2023 | 9 | 2023 |
| SEA-CD40 is a non-fucosylated anti-CD40 antibody with potent pharmacodynamic activity in preclinical models and patients with advanced solid tumors H Neff-LaFord, JE Grilley-Olson, DC Smith, B Curti, S Goel, TM Kuzel, ... Cancer Research 80 (16_Supplement), 5535-5535, 2020 | 6 | 2020 |
| Circulating Tumor DNA Dynamics as Early Outcome Predictors for Lisocabtagene Maraleucel as Second-Line Therapy for Large B-Cell Lymphoma from the Phase 3 TRANSFORM Study L Stepan, S Ansari, A Okal, J Dell'Aringa, E Thompson, A Crotta, VA Chow, ... Blood 142, 225, 2023 | 1 | 2023 |
| 438 Synergy between SEA-CD40 and chemotherapeutics drives curative antitumor activity in preclinical models W Zeng, H Neff-LaFord, S Ansari, C Jacquemont, M Schmitt, S Gardai Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 1 | 2020 |
| Undetectable MRD Status in Patients with R/R CLL/SLL with Stable Disease after Lisocabtagene Maraleucel Treatment: Exploratory Analysis of the TRANSCEND CLL 004 Study E Papp, S Ansari, J Wall, E Thompson, Y Chen, T Siddiqi, WG Wierda, ... Blood 142, 3263, 2023 | | 2023 |
| Biomarkers associated with complete metabolic response (CMR) to nivolumab and brentuximab vedotin (nivo+ BV) for the treatment of children, adolescents, and young adults (CAYA … C Garnett-Benson, R Ammar, R Crowe, S Francis, S Ansari, A Akyol Cancer Research 82 (12_Supplement), 5222-5222, 2022 | | 2022 |
| MAPPING THE LANDSCAPE OF INTERCELLULAR CROSSTALK IN THE LIVER BY SINGLE-CELL RNA-SEQUENCING T Liu, X Xiong, H Kuang, S Ansari, JZ Li, JD Lin HEPATOLOGY 70, 1329A-1330A, 2019 | | 2019 |
| Neighbor net analysis S Ansari, S Draghici | | 2019 |
| Integration Of Mutation And Gene Expression Data To Identify Disease Subtypes S Ansari Wayne State University, 2017 | | 2017 |
| Network-Based Approaches To Identify The Impacted Genes And Active Interactions S Ansari Wayne State University, 2017 | | 2017 |
| Package ‘ROntoTools’ C Voichita, S Ansari, MC Voichita, M biocViews NetworkAnalysis | | 2013 |
Sorin Draghici, IEEE FellowProfessor, Computer Science and Obstetrics and Gynecology, Wayne State University在 wayne.edu 的电子邮件经过验证
